Loading clinical trials...
Loading clinical trials...
The aim of this study is to quantify the incidence of eTIC (defined as an elevated appt) and hyperfibrinolysis (defined as Ly30\>7) in early trauma patients. To identify patients at risk of eTIC and h...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Medical University of Graz
NCT05468034 · Breast Cancer, Indolent Metastatic Breast Cancer
NCT07231419 · Diabetic Peripheral Neuropathic Pain
NCT06735690 · Acute Lymphoblastic Leukemia
NCT06303193 · Myelodysplastic Syndromes
NCT07486960 · Psoriatic Arthritis
Medical University of Graz
Graz
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions